Jump to content
World's Largest Herpes Support Group
Jimmyjimmyhuapua

CRISPR-Cas9 system-driven site-specific selection pressure on Herpes simplex virus genomesc

Recommended Posts

JHenry

In short,  layman’s terms, please capsulize the end result and significance.  Thanks!

Share this post


Link to post
Share on other sites
Dutchy

well if you can translate:P

Share this post


Link to post
Share on other sites
MikeHerp

In a nutshell, the significance is this:

"As a consequence, it [CRISPR-Cas9] provides a feasible selection approach for identifying drug-resistant viral strains or screening attenuated vaccines, as well as being applicable for viral vector construction and reverse genetics research.

So, CRISPR can also be used to:

1. Identify drug-resistant viral strains of HSV1.

2. Screen and develop for attenuated vaccines.

3.  Create HSV viral vectors for genetic editing purposes.

 

Purposes 1 and 2 may have some relevance and could help in the future with developing treatments.  Here they are not talking about using CRISPR to inhibit replication of HSV, but rather to more quickly identify drug resistant HSV strains and helping to create attenuated HSV vaccine candidates.

It is saying that CRISPR may help with existing efforts to find solutions to HSV drug resistance and could make it easier to identify and develop attenuated HSV vaccines.  It's good news, but not news that will itself lead to a product. Rather, CRISPR may be used as a tool to help develop products in the future.  

 

Share this post


Link to post
Share on other sites
MikeHerp

This research is interesting for several reasons.  Good find Jimmy.  

Share this post


Link to post
Share on other sites
ManagingIllness

This is basically the conclusion of the paper:

The CRISPR-Cas9 system can recognize and cleave viral genomic DNA viruses in 
eukaryotic cells, but due to the presence of high-efficiency DNA repair systems in the cells, the viral DNA genome could be repaired after cleavage. Viral genomes in eukaryotic cells cannot be eliminated because of these repair mechanisms; however, their ability to replicate and produce progeny virus is inhibited. Although the ability of the CRISPR-Cas9 system to inhibit viral replication is weakened in the presence of DNA repair systems, it could still work well directly on nuclear DNA and even recognize single-nucleotide differences. This provides a more generalized tool as an alternative to antibiotic or reporter gene selection. Furthermore, the system targets DNA sequences but is not dependent on protein function. As a consequence, it provides a feasible selection approach for identifying drug-resistant viral strains or screening attenuated vaccines, as well as being applicable for viral vector construction and reverse genetics research.

Share this post


Link to post
Share on other sites
Taintedgirl
Posted (edited)
21 minutes ago, ManagingIllness said:

This is basically the conclusion of the paper:

The CRISPR-Cas9 system can recognize and cleave viral genomic DNA viruses in 
eukaryotic cells, but due to the presence of high-efficiency DNA repair systems in the cells, the viral DNA genome could be repaired after cleavage. Viral genomes in eukaryotic cells cannot be eliminated because of these repair mechanisms; however, their ability to replicate and produce progeny virus is inhibited. Although the ability of the CRISPR-Cas9 system to inhibit viral replication is weakened in the presence of DNA repair systems, it could still work well directly on nuclear DNA and even recognize single-nucleotide differences. This provides a more generalized tool as an alternative to antibiotic or reporter gene selection. Furthermore, the system targets DNA sequences but is not dependent on protein function. As a consequence, it provides a feasible selection approach for identifying drug-resistant viral strains or screening attenuated vaccines, as well as being applicable for viral vector construction and reverse genetics research.

They don’t want to hear you say it might not work as a cure. The system is great but enhancements need to be made to ensure delivery to the nerves and effective cleavage 

Edited by Taintedgirl

Share this post


Link to post
Share on other sites
Untouchable1
5 hours ago, About Blank said:

A little bit of sloppy science going on apparently. The off-target effects reported initially were exaggerated and researchers were not able to duplicate them. This article was also interesting. I was intrigued by the last few paragraphs in the article below pertaining to our genetic codes. Any progress is good progress.

https://gizmodo.com/after-a-few-hiccups-all-bets-are-on-crispr-again-1823521006

Share this post


Link to post
Share on other sites
Voyager2
Posted (edited)

@aboutblank and @untouchable1: Thank you! Your links say a paper has been RETRACTED, a paper that last year warned of CRISPR causing all kinds of dire "off target mutations." That paper was not connected to Editas, ExBio or the Jerome lab, all of which continue to work on gene editing. The labs will still have to prove safety, but we can be glad this particular warning was retracted. Let's hope safety AND efficacy will be confirmed quickly when the method is applied to HSV in humans. We can be optimistic again.

Edited by Voyager2

Share this post


Link to post
Share on other sites
valleynovascotia

How many years away is this?

Share this post


Link to post
Share on other sites
Voyager2
On 4/18/2018 at 7:00 PM, valleynovascotia said:

How many years away is this?

I think ExBio gives 2019 or 2020 on their website as the beginning of human trials, so we should be able to start following the testing fairly soon. That will give us something to be hopeful about. 

Share this post


Link to post
Share on other sites
MikeHerp

 I'd read ExBio's website info more as aspirational hopes rather than something that will definitely happen.  This is a privately held company that has been looking for funding.

It's an open question whether they will actually do the HSV trials.  We will see.  

Share this post


Link to post
Share on other sites
lookingforanswers18

Not Sure where everyone is from but 60 minutes is supposed to have news coverage about CRISPR this evening, Sunday 4/29/18. I am not saying their coverage will be about HSV, but it could be good to watch for more information on Crispr.

Share this post


Link to post
Share on other sites
Dope1
18 hours ago, lookingforanswers18 said:

Not Sure where everyone is from but 60 minutes is supposed to have news coverage about CRISPR this evening, Sunday 4/29/18. I am not saying their coverage will be about HSV, but it could be good to watch for more information on Crispr.

https://www.cbsnews.com/news/crispr-the-gene-editing-tool-revolutionizing-biomedical-research/

Share this post


Link to post
Share on other sites
Ajuda
On 4/21/2018 at 6:26 AM, Voyager2 said:

Eu acho que o ExBio dá 2019 ou 2020 em seu site como o início de testes em humanos, por isso devemos ser capazes de começar a seguir os testes em breve. Isso nos dará algo para ser esperançoso. 

in my opinion, we must surely have hope, even that is what keeps me going. But the fact of being published in the 2019/2020 excisionbio pipeline does not mean that they will follow this timeline, even because the clinical trials were initially for 2018 and has been postponed. We need to move if we want this treatment. Some things do not depend on us (science), other things (interest / pressure). Someone needs to go to Philadelphia and press. If not, do not expect anything in 2019/20.
What's more, the development of HSV treatment depends on the advancement of HIV treatment. Unfortunately.

Share this post


Link to post
Share on other sites
lookingforanswers18

I agree, but how do we go about applying pressure? I've noticed on previous threads making moves have been discussed, but nothing has been done. Not having funds & Stigma is hindering us.

Share this post


Link to post
Share on other sites
Alot of H hate

I'm starting to have real hope thanks to crispr. I just wish some how some way it could get even more media attention so it could be fast tracked to help out everyone! Like serious question when can this be available to everyone??

Share this post


Link to post
Share on other sites
Taintedgirl
9 hours ago, Alot of H hate said:

I'm starting to have real hope thanks to crispr. I just wish some how some way it could get even more media attention so it could be fast tracked to help out everyone! Like serious question when can this be available to everyone??

It is being used in some places as a diagnostic tool which I think will be the case for a while because it has failed to remove any of the virus from the nerve cells. It only successfully worked for EBV 

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now

Advertisement

Try a Lysine supplement for cold sores

  • Similar Content

    • Nett
      By Nett
      www.community-labs.eu
       
      First of let me tell you the intention and why this can be a great project, good investment and eventually something we could all benefit from.
      A unique way of effort for funding our mutual problem with the ETH ERC20 Token.
      Labcash is my idea born by our mutual friend HSV.
      Just by looking at this forum I have noticed how much people complain about HSV funding (justified reason) and the institutions ignoring us at every possible step of the way.
         
            When I need a doctor I never use public health because it would take me 6 months to get in line, instead I go to a private doctor and get all done in 30 minutes.
      The same principle applies when we want something to be done such as HSV research, we can order a private laboratory that would conduct studies on our behalf without restrictions.
      Raising funds to start/continue and eventually complete a study is difficult especially when we know that repeated funding is necessary.
      The solution is offered by the blockchain and crypto assets.
      You may or may not be familiar with cryptocurrency however it has massive advantages such as competing against other cryptocurrencies on an exchange that directly benefits us as the value of the Token goes up gives us more investment power and not only that but we are able to make our own acyclovir product that will not feed the big pharma but our chosen investment lab and our token.
      The possible side effect is the volatility in the crypto market that would make the token more valuable than the initial purchase price making some extra profit for token holders (not the goal but a good one).
      Simplified:
      1. Tokens sold to HSV sufferers.
      2. Signing the contract with the laboratory for drug development (Pivot park in the Netherlands is the chosen default).
      3. Research begins.
      4. Production and packaging of acyclovir on the lowest possible price for packaging, shipping, and reinvestment to the blockchain.
      5. Sales and returns in the blockchain for future research.
      6. Eventual new drugs will be discovered thanks to passive funding/market exploitation.

      TECH
      Token name: Labcash
      Platform: ERC20
      Ticker: LCH
      If you are interested in participating in the project visit www.community-labs.eu or send an email on info@community-labs.eu for future clarification.
      If you are interested in buying the Token you will need a chrome extension called Metamask (all explained on the website) then you can buy the Token on this link:
      Buy Token
      As always doing something is always better than nothing :)
      If you have any questions ask here or send it to the info email.
      Cheers

       
    • Geometry
      By Geometry
      "For the first time, researchers have been able to use cryo-electron microscopy, to reveal the detailed structure of the common herpes virus."

      Sup y'all... this is the real-deal. The main problem with this disease has been that researchers literally haven't been able to see it... until now. So no wonder everything has failed miserably except our friend Valacyclovir Hydrochloride. It's amazing seeing this... isn't it kinda beautiful actually? This particular research was on HSV-1, but the work is ongoing and will be done on HSV-2 and all other herpes variants. If we can see it, we can kill it. I'll be paying attention to this research group like crazy now! 
      Here's one article: https://www.gla.ac.uk/news/headline_596519_en.html
      And here's the actual study- with pictures!
      https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.2006191
      Here's the guy doing the study (my new hero lol):
      https://www.gla.ac.uk/researchinstitutes/iii/staff/davidbhella/#/researchinterests,grants,publications,articles
      And here's the research's group on their HSV-1 work:
      https://www.gla.ac.uk/researchinstitutes/iii/cvr/aboutus/viruseswestudy/hsv1/
      So yeah just my opinion but finally no more shooting in the dark- drug companies will be all over this and start creating new treatments based on the actual structure of this damn organism, so I'm very hopeful indeed. 
    • AllHailKarma
      By AllHailKarma
      Anyone else actually legit ok? After doing the research, finding out how to keep myself healthy, how to keep this in dormacy, plus seeing how large of a community is on this side of the fence.... like, I'm good. And everyone else really should take the time to read, watch videos, figure out how your own body works with this shit, keep this community close also. We're all gonna be fine.  I'm more annoyed by occasional indigestion honestly.
    • destroyhsv
      By destroyhsv
      If you’ve followed this ASP2151 thread, you may know that I’ve been taking amenamevir (Amenalief) for about two months. In these two months, I have had absolutely no symptoms and no side effects to speak of. I’m ordering blood work soon to confirm that there are no major changes in important biomarkers (kidney, liver, heart, etc.) but I haven’t experienced any side effects that I could observe myself (headaches, diarrhea, insomnia, mood changes etc.) However, there is no data about the effectiveness of valacyclovir + amenamevir on reducing HSV recurrences. Two months of being on this combination is not enough to tell how well it works.
      As a community, what we need is a functional cure. There’s a lot of excitement surrounding pritelivir in this regard. Pritelivir, like amenamevir, is a new drug inhibits the HSV helicase-primase complex. This is a different target than valacyclovir, which is why combining the two has major potential to be a functional cure. If you’ve read Josh Bloom’s article on the possibility of using pritelivir and valacyclovir together as a sort of HIV-like cocktail, then you’ve probably realized this combo is the only way in the foreseeable future that we will have a functional cure.
      Here’s the reality of the situation.
      There will not be a vaccine in the foreseeable future (barring a miracle that allows GEN-003 to continue. I wouldn’t count on that).
      There will not be a CRISPR treatment in the foreseeable future.
      The only HSV drug that is going through clinical trials (past pre-clinical) is pritelivir. That means that aside from amenamevir and pritelivir, there will not be any new drugs on the market for at least ten years.
      You are not getting much help from the pharmaceutical companies. It’s the truth. Many people here are already aware of this. Look at the HSV pipeline. Other than the helicase-primase inhibitors, there is little to no progress being made, and the failure rate is incredibly high.
      If you want, you can wait ten years hoping that the pharmaceutical companies come out with something. The only alternative is to conduct our own trials and gather some data.
      There are plenty of drugs/supplements with studies that have some evidence to support their use in preventing HSV recurrences, but there’s not much consensus on whether they actually improve anything. A lot of them have been tested in animals, but not in humans for the purpose of reducing HSV recurrences. Others have been tested in early-stage trials with very small sample sizes and don’t achieve statistical significance, even if the results are promising:
      L-Glutamine
      Propranolol
      Aspirin & other COX-2 inhibitors Another link
      Lithium
      Lactoferrin
      and plenty more.
      Some people have also speculated that diet changes (ketogenic diet, intermittent fasting, etc.) also lead to dramatic improvement in symptoms. There is plenty of reason to be skeptical about these claims, especially when they only come from a small number of people. The sample size simply isn’t large enough.
      And, of course, there’s a new drug that we know to be a strong inhibitor of HSV replication: amenamevir. Just as famciclovir has the same effect on HSV as valacyclovir, amenamevir has the same effect on HSV as pritelivir. And, as some of you know, amenamevir is approved in Japan and can be purchased online.
      In many cases, valacyclovir by itself is not enough to stop all symptoms/recurrences. Additionally, valacyclovir doesn’t reduce shedding as much as it should. But research has found a strong correlation between number of recurrences and shedding. If we get recurrences down to zero, chances are that shedding is close to zero. At the very least, it means with very high probability that shedding has been significantly reduced.
      Clearly, to achieve a functional cure, valacyclovir is not enough. But when combined it with other drugs/supplements/diets, it could achieve a functional cure or at least eliminate all outbreaks (which all but guarantees a very low level of shedding). Hypothetically, valacyclovir might reduce the average number of outbreaks per year from 3 to 1. Taking amenamevir in combination with valacyclovir might reduce that number to .5. Taking glutamine with amenamevir and valacyclovir might reduce that number to .2 (this is just a hypothetical example). Many of these combos may have a synergistic effect, meaning that using both drugs together would have a stronger effect than the effects of each individual drug combined. And how will we actually figure this out? By doing our own clinical trial.
      We need a significant amount of participants. A trial will have at least sixty participants (more is better, but sixty is doable) for a three month period. I’ve created to gather some basic information about people (nothing personal or potentially identifying. Just things like age, time of diagnosis, frequency of outbreaks in the past year, whether or not they currently take medication. This data will help group the study participants properly) and a spreadsheet for a trial participant to record when they get an outbreak and to briefly describe the symptoms. The group will be split in half, with thirty participants taking only valacyclovir and the other half taking valacyclovir along with whatever we want to study in combination with valacyclovir. Other standard study procedures such as randomization of the groups will be incorporated into the trial. All the participants have to do is take the pills and record any outbreaks they have, briefly describe the symptoms, and write down when they are fully healed from the outbreak.
      At the end of the trial, we will have three months of data for sixty participants. That’s ninety months, or seven and a half years of data, in each group. If the valacyclovir group had a total of ten outbreaks, then the average number of recurrences per year would be about 1.3. If the combo group had a total of five outbreaks, then the average number of recurrences would be about .7. Finally, we test to see if the combo led to a statistically significant reduction in outbreaks compared to the valacyclovir only group. The larger the study group, the more statistically significant the findings will be, which is why a large number of participants is crucial.
      Finally, we finalize the trial by performing any other important data analysis. For example, we could see if there is any correlation between age and efficacy of the treatment. We generate graphs and charts and write a brief “paper” presenting the findings.
      The only one of these trials that would actually “cost” a lot of money would be an amenamevir trial (amenamevir, although available, is pretty expensive). However, if enough people are willing to participate in one, we could get data on what looks to be the most effective treatment that is currently available.
      A trial to assess the effect of any other drug, supplement, or diet would practically cost nothing. Aspirin, glutamine, lactoferrin, and propranolol are widely available and inexpensive, as are many of the other possible treatments, and these trials assume that participants are already taking valacyclovir whether it is covered by their insurance or not. And these trials do not require a major time commitment. The participant will have to verify at the beginning of the trial that they have the study drugs/supplements in their possession (just send a picture and blur out any personal info if there’s a prescription bottle). They take one or two pills a day and record any recurrences. In trials with potential side effects (e.g. lithium), the participant records any side effects. At the end of the study, the participant sends the spreadsheet over. That’s it.
      These studies and data may not be as high quality as that of many clinical trials, but they are certainly useful. By obtaining this data, we give ourselves the ability to treat this disease better than ever before. Instead of shooting fish in a barrel and hoping some supplement works because one person on the internet said it did or because a supplement had an effect in an animal study, you’ll be able to rely on real data from humans. Not only that, but that data will be on a combination of valacyclovir and whatever else is being taken, which there are very few if any human studies on.
      TL;DR: Doing crowdsourced trials on different combinations of valacyclovir and other compounds, we can see which compounds are effective for improving HSV. You can participate, and it is minimally time-consuming and costs next to nothing (unless you want to do an amenamevir trial). Participating will help us gather data to improve our conditions dramatically.
      If you’re interested in participating, please fill out this form: https://goo.gl/forms/Q50PKY8I11tVMsLh2
      I am not interested in anyone’s personal data. These studies are to remain anonymous and I will never ask for or attempt to collect any personal data. The only reason I ask for age in the form is because is a potential variable to account for in data analysis. You do not need to provide your age if you don't want to.
      All communications should be done through this website’s messaging system or using an email that does not link to your identity. You can reach me at honeycombstudy at gmail.com or message me on this site.
      Any questions and/or skepticism are more than welcome.
      Finally, if anyone would like to contribute to this project please contact me! Let’s start taking action.

       
  • Trending Now

  • The Hive is Thriving!

    • Total Topics
      68,885
    • Total Posts
      460,911
  • Posts

    • joescrilla
      More confusion! So the results have come back for both of the partners that I've been with over the last 3-4 years and they are both negative for type 1 and type 2. Where do I go next? Any advice?
    • Gems
      please look through the forum in exact and careful detail and inform yourself of less than usual circumstances to cover yourself.

      auto inoculation is rare and it can happen. off objects is debated but some people claim it happens. some people have experienced it happens easily.

      so you know practice good hygiene. i personal think use a heated towel rail and make sure your towels are fully hot and dry. there were studies in the 80's showing it can live on towels for 75 hours. The herpes association say most experts agree it cannot be caught off a towel. That is most experts not all. Some people end up with it on their body and one has to wonder how? Towels I would guess.

      Things that tend to stay kinda wet or so on. cups are another one that fit that i think.

      I remember being at university once and being in the bathroom while a girl was on the phone to her friend.She thought she had a bite on her face but clear to me someone with herpes had kissed her on the cheek recently, it didnt look typical just her skin peeling. 

      I am not an expert though or a doctor so do your own research.  
       
    • Phoenixx
      Update: The creme that contains the tetrapodal zinc oxide still isn't available at Gorch Fock Apotheke Kiel. I called them today: same status as last year and they have no further information on when and if it will be available again.
    • Phoenixx
      Lilian, the zinc acetate we are talking about here is different from the tetrapodal zinc oxide that you are mentioning. But thanks for the reminder. The ointment that contains the tetrapodal zinc oxide still isn't available at Gorch Fock Apotheke Kiel. I called them today: same status as last year and they have no further information on when and if it will be available again.
    • Gems
      I've had neg swabs but I am sure you'll get it. Follow the process. I haven't read the thread in exact detail, but if you have documentation of doctors mishandling your case when you get/ if you get a poss inform them in writing as well as the medical board I think.  Under diagnosis is as problematic as false pos and reducing transmission is good.
×

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.